Protagonist Therapeutics Surges On Plans To Join S&P SmallCap 600

Protagonist Therapeutics Surges On Plans To Join S&P SmallCap 600 · Investor's Business Daily

In This Article:

Protagonist Therapeutics is poised to join the S&P SmallCap 600 next Wednesday, replacing copper and aluminum wire manufacturer Encore Wire.